BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

Core Insights - BrainsWay has completed a $1 million milestone-based investment in Axis Management Company, Inc. to enhance access to mental health care [1] - The investment follows Axis's achievement of a revenue performance milestone as part of a strategic equity financing agreement established in August 2025 [1][2] Company Overview - BrainsWay is a leader in noninvasive neurostimulation treatments for mental health disorders, utilizing its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) technology [5] - The company has received FDA clearance for three indications: major depressive disorder, obsessive-compulsive disorder, and smoking addiction [5] - BrainsWay aims to increase global awareness and access to Deep TMS through ongoing clinical trials in various psychiatric and neurological disorders [5] Axis Management Company - Axis Integrated Mental Health provides management services to mental health clinics in Colorado, focusing on a comprehensive and integrative model of care [6] - The organization combines modern psychiatry and psychotherapy with advanced treatments, including Deep TMS™ and Spravato®, to deliver holistic therapeutic approaches [6]